We are international
• about myeloma TEXT SIZE   
consolidation & maintenance: are they needed?    back

ASH 2010 Highlights for Patients with Myeloma
Summaries of Multiple Myeloma Presentations from the 52nd Annual Meeting of the American Society for Hematology (ASH) held in Orlando, Florida
December 4–7, 2010
Compiled by Lynne Lederman, PhD

The 52nd Annual Society of Hematology (ASH) Annual Meeting was held December 4th through 7th, 2010, in Orlando, FL. This report summarizes presentations at the 2010 ASH Annual Meeting, organized by topics rather than by sessions, providing an overview of information on new drugs in development; clinical trial results; treatment by patient characteristics, e.g., transplant eligibility or stage of disease; risk stratification and staging; disease biology including bone disease and use of bisphosphonates; and maintenance therapy. Although maintenance therapy is summarized in its own section, some trials that include maintenance therapy are summarized in more appropriate sections, as many trials are now including some kind of continuing treatment for at least some patients.

Click on the PDF tab above to read and/or download the document.

 related articles